High-Deductible Health Plans Linked to Delayed Diagnosis of Metastatic Cancer

High-Deductible Health Plans Linked to Delayed Diagnosis of Metastatic Cancer

header-info

Enrollment in high-deductible health plans (HDHPs) is associated with delays in the diagnosis of metastatic cancer, according to research presented at the 2022 ASCO Annual Meeting.